Reaping the Whirlwind of Nazi Eugenics
By Kate Douglas,
New Scientist
| 07. 14. 2014
Untitled Document
Are some fields of scientific exploration so incendiary they should be fenced off and labelled "Keep out"?
I'm inclined to think not, both from a commitment to intellectual freedom and for the practical reason that if you put up such notices, trespassers are guaranteed. Still, if any area of research might warrant prohibition it is eugenics – the branch of human genetics used to justify repugnant Nazi ideology and, before that, the enforced sterilisation of "degenerates" around the world.
Yet eugenics was not cordoned off. A mere two decades after the second world war, it was reinvented as behaviour genetics. The story of what happened next is both gripping and salutary – and it is told with wonderful insight by sociologist Aaron Panofsky from the Institute of Society and Genetics at the University of California, Los Angeles.

It is testament to human resilience and optimism that behaviour genetics was born into an atmosphere of academic excitement. Seen as an antidote to behaviourism – the idea that behaviour can be scientifically understood without recourse to anything beyond the observable...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...